Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 3',5'-diesters of 5-fluoro-2'-deoxyuridine: synthesis and biological activity.

× No keyword cloud information.

11 in total

1. Nonenzymatic and enzymatic hydrolysis of 5-fluoro-2'-deoxyuridine (FUdR) esters.

Authors: T Kawaguchi; S Fukushima; Y Hayashi; M Nakano
Journal: Pharm Res Date: 1988-11 Impact factor: 4.200

2. Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism.

Authors: Christopher P Landowski; Xueqin Song; Philip L Lorenzi; John M Hilfinger; Gordon L Amidon
Journal: Pharm Res Date: 2005-08-24 Impact factor: 4.200

3. Characteristics of association of oleoyl derivatives of 5-fluorodeoxyuridine and methotrexate with low-density lipoproteins (LDL).

Authors: P C de Smidt; T J van Berkel
Journal: Pharm Res Date: 1992-04 Impact factor: 4.200

Review 4. Recent trends in targeted anticancer prodrug and conjugate design.

Authors: Yashveer Singh; Matthew Palombo; Patrick J Sinko
Journal: Curr Med Chem Date: 2008 Impact factor: 4.530

5. The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stability.

Authors: Yasuhiro Tsume; Tuba Incecayir; Xueqin Song; John M Hilfinger; Gordon L Amidon
Journal: Eur J Pharm Biopharm Date: 2013-12-19 Impact factor: 5.571

6. Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver.

Authors: Diana Vivian; James E Polli
Journal: Int J Pharm Date: 2014-09-16 Impact factor: 5.875

7. Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.

Authors: A Mori; S J Kennel; M van Borssum Waalkes; G L Scherphof; L Huang
Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333

8. Antitumor activity of 3',5'-diesters of 5-fluoro-2'-deoxyuridine against murine leukemia L1210 cells.

Authors: F Kanzawa; A Hoshi; K Kuretani; M Saneyoshi; T Kawaguchi
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

9. Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells.

Authors: G A Koning; A Gorter; G L Scherphof; J A Kamps
Journal: Br J Cancer Date: 1999-08 Impact factor: 7.640

10. Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.

Authors: Yasuhiro Tsume; John M Hilfinger; Gordon L Amidon
Journal: Mol Pharm Date: 2008-07-25 Impact factor: 4.939